Combination of SH003 and paclitaxel modulates tumor microenvironment and inhibit...

연구 요약

Combination of SH003 and paclitaxel modulates tumor microenvironment and inhibits metastasis of metastatic melanoma.

Medical oncology (Northwood, London, England) 학술지에 발표된 이 연구는 Lee SE, Kim MW, Sim YB 외 연구팀이 수행하였습니다.

이 연구는 'Combination of SH003 and paclitaxel modulates tumor microenvironment and inhibits metastasis of metastatic melanoma.'에 대한 과학적 분석을 제공합니다.

핵심 내용

Developing therapeutic strategies to overcome immune evasion and resistance posed by the tumor microenvironment (TME) in advanced melanoma remains a significant challenge. This study evaluated therapeutic efficacy of an anticancer herbal extract SH003 combined with Paclitaxel (PTX) in a metastatic melanoma model. Results indicated that the combined therapy of SH003 and PTX not only bolstered antitumor immune responses by reducing influx of regulatory T cells (Tregs) and enhancing infiltration of cytotoxic T cells within the TME, but also significantly curtailed tumor growth and metastasis. Notably, the combined therapy of SH003 and PTX effectively inhibited the EGFR/JAK2/STAT3 and PI3K/AKT/mTOR signaling pathways, which are closely associated with tumor cell survival. Additionally, it reduced the expression of markers associated with metastasis, such as MMP-2, MMP-9, N-cadherin, CXCL9, and CXCL10. These findings suggest that SH003 in combination with PTX can reshape the TME, improve immune cell infiltration, and enhance antitumor immunity, offering a promising strategy to improve therapeutic outcomes of metastatic melanoma.

일반인을 위한 해석

구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.

실천 사항

• 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
• 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
• 이상 반응이 나타나면 즉시 전문가에게 문의하세요

의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 41249641)

📄 [전문 보기 (Markdown)](fulltext/41249641-combination-of-sh003-and-paclitaxel-modulates-tumor-microenv.md)